Wordt geladen...
Naltrexone/Bupropion: An Investigational Combination for Weight Loss and Maintenance
Naltrexone/bupropion is an investigational combination for weight loss and maintenance in patients who are obese or have a BMI ≧ 27 kg/m(2) with comorbid diabetes, hypertension or hyperlipidemia. Pooled results from four phase 3 trials reveal placebo-subtracted mean weight loss of 4.7% (range 3.2–5....
Bewaard in:
| Gepubliceerd in: | Obes Facts |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
S. Karger AG
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6444555/ https://ncbi.nlm.nih.gov/pubmed/22249001 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000335352 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|